Takeda to sell Japanese consumer health unit to Blackstone for $2.3 billion

Takeda Pharmaceutical Co has agreed to sell its Japanese consumer healthcare business to U.S. investment fund Blackstone Group for 242 billion yen ($2.3 billion), Japan’s largest drugmaker said on …
( read original story …)

---